iShares Genomics Immunology and Healthcare ETF
Not enough financial coverage to compute a composite score for IDNA. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.ishares.com/us/products/308878/ishares-genomics-immunology-and-healthcare-etf
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
- IPO
- 2019
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $165.06M
- Div Yield
- 1.06%
Performance & Tape
- 52W High
- $31.41
- 52W Low
- $19.86
- 50D MA
- $29.46
- 200D MA
- $26.79
- Beta
- 1.11
- Avg Volume
- 39.71K
Get TickerSpark's AI analysis on IDNA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IDNA Coverage
We haven't published any research on IDNA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IDNA Report →